ResearcherJohns Hopkins UniversityNo recent work listed

Anne M. Macgregor-Das

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3452-5019; OpenAlex author ID A5102961598. Sources: OpenAlex.

Their work

Papers: 4
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 32

Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 4

Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer. Co-author DOI 10.1016/j.cgh.2021.10.008 ↗
Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing. Co-author DOI 10.1016/j.jmoldx.2020.02.010 ↗
Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. Co-author DOI 10.1073/pnas.1720588115 ↗
Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. Co-author DOI 10.1200/jco.2017.72.3502 ↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jin Peng He · 4 shared papers, 2017–2022 · strength 0.33
- Paper Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer. DOI 10.1016/j.cgh.2021.10.008 ↗
- Paper Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing. DOI 10.1016/j.jmoldx.2020.02.010 ↗
- Paper Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. DOI 10.1073/pnas.1720588115 ↗
Michael Goggins · 4 shared papers, 2017–2022 · strength 0.33
- Paper Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer. DOI 10.1016/j.cgh.2021.10.008 ↗
- Paper Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing. DOI 10.1016/j.jmoldx.2020.02.010 ↗
- Paper Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. DOI 10.1073/pnas.1720588115 ↗
Marcia Irene Canto · 3 shared papers, 2018–2022 · strength 0.27
- Paper Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer. DOI 10.1016/j.cgh.2021.10.008 ↗
- Paper Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing. DOI 10.1016/j.jmoldx.2020.02.010 ↗
- Paper Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. DOI 10.1073/pnas.1720588115 ↗
Toshiya Abe · 3 shared papers, 2018–2022 · strength 0.27
- Paper Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer. DOI 10.1016/j.cgh.2021.10.008 ↗
- Paper Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing. DOI 10.1016/j.jmoldx.2020.02.010 ↗
- Paper Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. DOI 10.1073/pnas.1720588115 ↗
Richard Andrew Burkhart · 2 shared papers, 2020–2022 · strength 0.22
- Paper Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer. DOI 10.1016/j.cgh.2021.10.008 ↗
- Paper Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing. DOI 10.1016/j.jmoldx.2020.02.010 ↗
Koji Tamura · 2 shared papers, 2017–2022 · strength 0.19
- Paper Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer. DOI 10.1016/j.cgh.2021.10.008 ↗
- Paper Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. DOI 10.1200/jco.2017.72.3502 ↗
Masaya Suenaga · 3 shared papers, 2017–2020 · strength 0.19
- Paper Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing. DOI 10.1016/j.jmoldx.2020.02.010 ↗
- Paper Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. DOI 10.1073/pnas.1720588115 ↗
- Paper Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. DOI 10.1200/jco.2017.72.3502 ↗
Jun Yu · 3 shared papers, 2017–2020 · strength 0.19
- Paper Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing. DOI 10.1016/j.jmoldx.2020.02.010 ↗
- Paper Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. DOI 10.1073/pnas.1720588115 ↗
- Paper Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. DOI 10.1200/jco.2017.72.3502 ↗
Koji Shindo · 3 shared papers, 2017–2020 · strength 0.19
- Paper Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing. DOI 10.1016/j.jmoldx.2020.02.010 ↗
- Paper Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. DOI 10.1073/pnas.1720588115 ↗
- Paper Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. DOI 10.1200/jco.2017.72.3502 ↗
Christopher Lee Wolfgang · 3 shared papers, 2017–2020 · strength 0.19
- Paper Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing. DOI 10.1016/j.jmoldx.2020.02.010 ↗
- Paper Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. DOI 10.1073/pnas.1720588115 ↗
- Paper Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. DOI 10.1200/jco.2017.72.3502 ↗
Alison P. Klein · 3 shared papers, 2017–2020 · strength 0.19
- Paper Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing. DOI 10.1016/j.jmoldx.2020.02.010 ↗
- Paper Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. DOI 10.1073/pnas.1720588115 ↗
- Paper Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. DOI 10.1200/jco.2017.72.3502 ↗
Ralph H. Hruban · 3 shared papers, 2017–2020 · strength 0.19
- Paper Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing. DOI 10.1016/j.jmoldx.2020.02.010 ↗
- Paper Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. DOI 10.1073/pnas.1720588115 ↗
- Paper Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. DOI 10.1200/jco.2017.72.3502 ↗
Amanda L. Blackford · 1 shared paper, 2022 · strength 0.14
- Paper Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer. DOI 10.1016/j.cgh.2021.10.008 ↗
Haruyoshi Tanaka · 1 shared paper, 2022 · strength 0.14
- Paper Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer. DOI 10.1016/j.cgh.2021.10.008 ↗
Takeichi Yoshida · 1 shared paper, 2022 · strength 0.14
- Paper Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer. DOI 10.1016/j.cgh.2021.10.008 ↗
Anne Marie Lennon · 1 shared paper, 2022 · strength 0.14
- Paper Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer. DOI 10.1016/j.cgh.2021.10.008 ↗
Koji Tamura · 2 shared papers, 2018–2020 · strength 0.14
- Paper Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing. DOI 10.1016/j.jmoldx.2020.02.010 ↗
- Paper Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. DOI 10.1073/pnas.1720588115 ↗
James R. Eshleman · 2 shared papers, 2018–2020 · strength 0.14
- Paper Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing. DOI 10.1016/j.jmoldx.2020.02.010 ↗
- Paper Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. DOI 10.1073/pnas.1720588115 ↗
Matthew John Weiss · 2 shared papers, 2017–2018 · strength 0.10
- Paper Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. DOI 10.1073/pnas.1720588115 ↗
- Paper Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. DOI 10.1200/jco.2017.72.3502 ↗
Nicholas Jason Roberts · 2 shared papers, 2017–2018 · strength 0.10
- Paper Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. DOI 10.1073/pnas.1720588115 ↗
- Paper Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. DOI 10.1200/jco.2017.72.3502 ↗
Shiro Kohi · 1 shared paper, 2020 · strength 0.08
- Paper Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing. DOI 10.1016/j.jmoldx.2020.02.010 ↗
Marco Dal Molin · 1 shared paper, 2020 · strength 0.08
- Paper Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing. DOI 10.1016/j.jmoldx.2020.02.010 ↗
Sara H. Olson · 1 shared paper, 2018 · strength 0.05
- Paper Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. DOI 10.1073/pnas.1720588115 ↗
Tatsuo Hata · 1 shared paper, 2018 · strength 0.05
- Paper Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. DOI 10.1073/pnas.1720588115 ↗
Randall E. Brand · 1 shared paper, 2018 · strength 0.05
- Paper Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. DOI 10.1073/pnas.1720588115 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.